According to GlobalData, SILARIS is one of 160 product lines sold in the US respiratory disease tests market; these product lines are sold by 75 different manufacturers. The price of the SILARIS device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.
The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.
In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Sekisui Chemical apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.
Sekisui Chemical overview
Sekisui Diagnostics UK Ltd (Sekisui Diagnostics) is the UK-based manufacturer of dental and medical instruments and supplies. It offers enzymes for medical diagnostics and bio-pharmaceutical companies. The company is also engaed in distribution and sales of rapid tests and clinical chemistry reagents. Sekisui Diagnostics is headquatered in Kent, Greater London, the UK.
For a complete picture of SILARIS, Respiratory Disease Tests pricing in the US, buy the report here.